• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554

Recent Advances in the Study of 3-amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one (CAS: 1684425-51-1)

The compound 3-amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one (CAS: 1684425-51-1) has recently garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential therapeutic applications. This heterocyclic scaffold is of particular interest for its role as a key intermediate in the synthesis of bioactive molecules, including kinase inhibitors and other small-molecule modulators of cellular pathways. Recent studies have explored its utility in drug discovery, focusing on its pharmacokinetic properties, synthetic accessibility, and biological activity.

One of the most notable advancements in this area is the development of novel synthetic routes to access 3-amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one derivatives with improved yields and purity. Researchers have employed multi-step organic transformations, including cyclization and functional group modifications, to optimize the synthesis of this compound. These efforts have been complemented by computational studies to predict the reactivity and stability of the scaffold under various conditions, providing valuable insights for further chemical modifications.

In terms of biological applications, recent investigations have highlighted the potential of 3-amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one as a pharmacophore in the design of kinase inhibitors. Preclinical studies have demonstrated its ability to selectively target specific kinases involved in oncogenic signaling pathways, making it a promising candidate for cancer therapy. Additionally, its structural versatility allows for the incorporation of diverse substituents, enabling the fine-tuning of its biological activity and selectivity.

Further research has also explored the compound's role in modulating other biological targets, such as G-protein-coupled receptors (GPCRs) and epigenetic enzymes. These studies have revealed its potential in treating a broad range of diseases, including inflammatory disorders and neurodegenerative conditions. The compound's favorable physicochemical properties, such as solubility and metabolic stability, further enhance its attractiveness as a drug candidate.

Looking ahead, ongoing research aims to expand the therapeutic applications of 3-amino-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-4-one through structure-activity relationship (SAR) studies and in vivo efficacy evaluations. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these findings into clinical development. As the understanding of this compound's mechanisms of action deepens, it is poised to play a pivotal role in the next generation of targeted therapies.

• 459157-51-8(Pyrazolo[1,5-a]pyrazine-2-carboxamide, 3-amino-5-ethyl-4,5,6,7-tetrahydro-4-oxo- (9CI))
• 1189579-85-8(3-amino-4,5,6,7-tetrahydro-4-oxo-Pyrazolo[1,5-a]pyrazine-2-carboxamide)
• 2101196-77-2(4-amino-N-[2-(diethylamino)ethyl]-1-propyl-1H-pyrazole-5-carboxamide)
• 2041076-41-7(3-Amino-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one hydrochloride)
• 2170752-17-5(Pyrazolo[1,5-a]pyrazin-4(5H)-one, 3-amino-6,7-dihydro-5-(1-methylethyl)-)
• 2101196-09-0(4-amino-N-ethyl-N-methyl-1-propyl-1H-pyrazole-5-carboxamide)
• 1189579-87-0(3-amino-4,5,6,7-tetrahydro-5-methyl-4-oxo-Pyrazolo[1,5-a]pyrazine-2-carboxamide)
• 1006453-64-0(4-amino-N,1-diethyl-1H-pyrazole-5-carboxamide)
• 1006453-68-4(4-amino-1-ethyl-N-(2-methylpropyl)-1H-pyrazole-5-carboxamide)
• 109421-46-7(1H-Pyrazole-5-carboxamide, 4-amino-1-ethyl-3-methyl-N-propyl-)